Enhanced Recovery Protocol After Cesarean Section
ERAC
Effectiveness of Implementing Enhanced Recovery After Cesarean Section Protocol on Maternal and Neonatal Outcomes
1 other identifier
interventional
108
1 country
1
Brief Summary
This study aims to evaluate the effectiveness of implementing the Enhanced Recovery After Cesarean (ERAC) protocol on maternal and neonatal outcomes. Research hypotheses To fulfill the aim of the study, the following research hypotheses are formulated: Hypothesis I: Women who receive the ERAC protocol experience faster recovery compared to those who receive routine hospital nursing care. Hypothesis II: Women who receive the ERAC protocol experience fewer maternal and neonatal complications than those who receive routine hospital nursing care.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Feb 2025
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 30, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
October 30, 2025
CompletedFirst Submitted
Initial submission to the registry
July 14, 2026
CompletedFirst Posted
Study publicly available on registry
July 22, 2026
CompletedJuly 22, 2026
July 1, 2026
8 months
July 14, 2026
July 21, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Maternal quality of recovery score
Maternal quality of recovery will be measured using a 40-item questionnaire. Each item is rated on a three-point Likert scale: 1 = rarely, 2 = sometimes, and 3 = always. Scores are reversed for negatively worded items. Total scores range from 40 to 120, with higher scores indicating better quality of recovery and lower scores indicating poorer quality of recovery.
at day 0 and 2 weeks postoperative
Secondary Outcomes (9)
Incidence of intraoperative hypotension
day 0 of surgery
Incidence of intraoperative nausea and vomiting
During cesarean delivery.
Time to first semisolid food intake
From completion of surgery until first semisolid food intake during hospitalization.
Time to first ambulation
From completion of surgery until first ambulation during hospitalization.
Hospital length of stay
From completion of surgery until hospital discharge.
- +4 more secondary outcomes
Study Arms (2)
Experimental :ERAC arm (intervention)
EXPERIMENTALThe intervention group will receive the Enhanced Recovery After Cesarean (ERAC) protocol of care, consisting of the following components: Preoperative care: * Patient education. * Reduced preoperative fasting: solid food will be permitted until 6 hours before surgery, and clear fluids until 2 hours before surgery. * Preoperative carbohydrate loading. Intraoperative care: * Antibiotic prophylaxis. * Thermal regulation using active warming methods, warmed intravenous fluids, and maintenance of an appropriate operating room temperature. * Neuraxial anesthesia with strategies to prevent maternal hypotension. * Delayed cord clamping for 30-60 seconds after birth. * Immediate maternal-newborn bonding through skin-to-skin contact and early initiation of breastfeeding in the operating room, when clinically feasible. Postoperative care: • Prophylaxis for pos
Routine care arm
ACTIVE COMPARATORThe control group will receive routine nursing care only (pre-operative, intraoperative and postoperative).NPO for at least 8 hrs for food and fluid ,immediate cord clamping ,no mutlimodal analgesia ,catheter removal after at least 12 hrs
Interventions
The control group will receive routine preoperative, intraoperative, and postoperative nursing care according to standard hospital practice. Preoperative care: • Fasting from both food and fluids for at least 8 hours before surgery. Intraoperative care: • Immediate umbilical cord clamping after birth. Postoperative care: * Analgesia according to routine hospital practice without a standardized multimodal analgesic regimen. * Urinary catheter removal at least 12 hours after surgery.
• The intervention group will receive the Enhanced Recovery after Cesarean protocol of Care which consists of: Preoperative Care: * Patient education covering the procedure, perioperative expectations, pain management plan, early oral intake and mobilization goals, discharge criteria, and follow-up schedule. * Minimizing fasting: Solid food allowed up to 6 hours and clear fluids up to 2 hours prior to surgery. * Carbohydrate loading: Administration of 45g non-particulate carbohydrate drink up to 2 hours before surgery for non-diabetic mothers. Intraoperative Care: * Antibiotic prophylaxis: Administered within 60 minutes prior to skin incision. * Thermal regulation: Use of active warming methods, warmed IV fluids, and maintaining operating room temperature \>72.8°F (22.7°C). * Anesthesia: Neuraxial anesthesia with hypotension prevention strategies (fluid preloading/co-loading and phenylephrine infusion). * Delayed cord clamping: For 30-60 seconds after birth. * Immediate maternal-newborn
Eligibility Criteria
You may qualify if:
- Women undergoing planned cesarean delivery.
- Scheduled to receive neuraxial anesthesia.
- Gestational age of 37 weeks or more.
- Singleton pregnancy.
You may not qualify if:
- Women requiring additional interventions outside the Enhanced Recovery After Cesarean (ERAC) pathway, including severe coagulopathy or active infection.
- Women expected to require prolonged hospitalization because of a history of uterine rupture, pre-existing hypertension, pregnancy-induced hypertension, or placenta accreta.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Mansoura University Hospital
Al Mansurah, Dakhalia, 34511, Egypt
Study Officials
- PRINCIPAL INVESTIGATOR
Noura G El-Gamel, MSc
Mansoura University
- STUDY CHAIR
Enas S Fathy
Mansoura University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Masking Details
- This study will be conducted as a single-blind randomized controlled trial, where participants will be blinded to group allocation.
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Lecturer
Study Record Dates
First Submitted
July 14, 2026
First Posted
July 22, 2026
Study Start
February 1, 2025
Primary Completion
September 30, 2025
Study Completion
October 30, 2025
Last Updated
July 22, 2026
Record last verified: 2026-07
Data Sharing
- IPD Sharing
- Will not share
Individual participant data will not be shared because the participants' informed consent and institutional ethical approval did not include external sharing of participant-level data. Aggregate study findings will be reported in scientific publications.